Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?

Ofei SY; Gariepy C; Hanje J; Sisk T; Daniels CJ; Zaidi AN

doi:10.1016/j.ijcard.2014.12.031

Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?

Ofei SY, Gariepy C, Hanje J, Sisk T, Daniels CJ …

Palabras clave — elegidas por los autores Congenital heart disease, FibroSure, Fontan, Hepatic fibrosis, Single ventricle

MeSH — NLM indexing Adolescent Adult Female Fontan Procedure / adverse effects Fontan Procedure / trends Humans Liver Cirrhosis / diagnosis Liver Cirrhosis / etiology Male Mass Screening / trends Predictive Value of Tests Severity of Illness Index Young Adult

Acciones del personal

Descargar PDF

Los archivos son para uso autorizado únicamente en los canales asociados de BioPredictive.

Fibrotest Actitest Letter Independent Group United States

Autores (6)

Ofei SY — Nationwide Children's Hospital/The Ohio State University, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: sylvia.ofei@nationwidechildrens.org.
Gariepy C — Nationwide Children's Hospital/The Ohio State University, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: cheryl.gariepy@nationwidechildrens.org.
Hanje J — Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: james.hanje@osumc.edu.
Sisk T — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: tracey.sisk@nationwidechildrens.org.
Daniels CJ — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA; Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: curt.daniels@nationwidechildrens.org.

Ofei SY — Nationwide Children's Hospital/The Ohio State University, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: sylvia.ofei@nationwidechildrens.org.
Gariepy C — Nationwide Children's Hospital/The Ohio State University, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: cheryl.gariepy@nationwidechildrens.org.
Hanje J — Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: james.hanje@osumc.edu.
Sisk T — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: tracey.sisk@nationwidechildrens.org.
Daniels CJ — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA; Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: curt.daniels@nationwidechildrens.org.
Zaidi AN — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA; Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: azaidi@montefiore.org.

Cita

Ofei SY, Gariepy C, Hanje J, Sisk T, Daniels CJ, Zaidi AN. Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?. Int J Cardiol. 2015;181:174-5. doi:10.1016/j.ijcard.2014.12.031.

Identificadores

DOI: 10.1016/j.ijcard.2014.12.031
PMID: 25528305

Pruebas

Enfermedades hepáticas

Lesiones hepáticas

Comparaciones

Temas

Región

Carrito

Su carrito está vacío.

Explore las publicaciones y use Añadir al carrito en cualquier página de detalle para crear un archivo ZIP que pueda enviar a los clientes.

Explorar las publicaciones

Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?

Más sobre el mismo tema

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Noninvasive Assessment of Liver Fibrosis.

Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.

Toward non-invasive assessment strategies in autoimmune hepatitis.